Area of research
Cancer Research · Oncology
Research interest
Research interests include Breast cancer, Medicine, Oncology, Internal medicine, Triple-negative breast cancer, and Tissue microarray.
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.
Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients